bTAE-HAIC Combined With System Therapy for Intermediate-advanced Huge HCC

Clinical trial NCT06061276 · RECRUITING

Trial details

NCT number: NCT06061276
Sponsor: Sun Yat-sen University
Status: RECRUITING
Phase: Not Applicable
Study type: INTERVENTIONAL

Liver Diseases Hepatocellular Carcinoma Immunotherapy Camrelizumab Lenvatinib

Start date: 2024-05-20
Primary completion: 2025-06-30
Enrollment: 40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.